Eisai Co (TSE:4523) Days Sales Outstanding

: 97.07 (As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

Eisai Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円189,046 Mil. Eisai Co's Revenue for the three months ended in Dec. 2023 was 円177,703 Mil. Hence, Eisai Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 97.07.

The historical rank and industry rank for Eisai Co's Days Sales Outstanding or its related term are showing as below:

TSE:4523' s Days Sales Outstanding Range Over the Past 10 Years
Min: 87.47 Med: 96.53 Max: 120.08
Current: 91.91

During the past 13 years, Eisai Co's highest Days Sales Outstanding was 120.08. The lowest was 87.47. And the median was 96.53.

TSE:4523's Days Sales Outstanding is ranked worse than
68.47% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.93 vs TSE:4523: 91.91

Eisai Co's Days Sales Outstanding increased from Dec. 2022 (89.29) to Dec. 2023 (97.07).

Eisai Co Days Sales Outstanding Historical Data

The historical data trend for Eisai Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

87.47

88.33

96.16

88.87

96.89

Eisai Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															89.29	86.61	87.22	98.45	97.07

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eisai Co Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Eisai Co's Days Sales Outstanding falls into.

Eisai Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Eisai Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (207950	+	187256)	/	2 )	/	744402	*	365
=	197603					/	744402	*	365
=	96.89

Eisai Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (191910	+	186182)	/	2 )	/	177703	*	365 / 4
=	189046					/	177703	*	365 / 4
=	97.07

Eisai Co (TSE:4523) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Eisai Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Eisai Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (TSE:4523) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ESAIY:USA ESALF:USA EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines